• Aucun résultat trouvé

[PDF] Top 20 Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies

Has 10000 "Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies" found on our website. Below are the top 20 most common "Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies".

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies

... Evaluation and comparison of the analytical performances Table 3 summarizes the analytical performances of the NovaLisa SARSCoV2 (COVID‐19) IgG, ... Voir le document complet

10

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies

... cut-off for IgM compared to IgG was only modest ( Table 2 ...kinetics of IgM and IgG on a smaller cohort ...patients) and observed a 100% sensitivity ... Voir le document complet

6

Distinct systemic and mucosal immune responses to SARS-CoV-2

Distinct systemic and mucosal immune responses to SARS-CoV-2

... Systemic and mucosal antibody responses in COVID-19 patients Little is known about how systemic and nasopharyngeal humoral immune responses are coordinated during SARS-CoV-2 ... Voir le document complet

41

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients

... one of non-hospitalized patients, including asymptom- atic ...total of 197 patients with a confirmed SARS-CoV-2 RT-PCR were retrospectively included from March 21 to October 27, ... Voir le document complet

6

Challenges and Issues of Anti-SARS-CoV-2 Vaccines

Challenges and Issues of Anti-SARS-CoV-2 Vaccines

... Irrespective of the presence of symptoms, the virus induces production of specific antibodies, following a pattern similar to that observed in most viral infections: rapid production ... Voir le document complet

12

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

... categories of immunoassays exist and allow, depending on the tests, to detect the presence of IgG, IgA and IgM in response to a SARS-CoV-2 infection: ... Voir le document complet

9

SARS-CoV-2 in carotid body

SARS-CoV-2 in carotid body

... metabolic and immune sensing, and could also be a route of nervous system invasion by ...Involvement of the carotid body by SARS- CoV-2 may explain silent hypoxemia ... Voir le document complet

2

Place de la serologie dans l’infection au sars-cOv-2

Place de la serologie dans l’infection au sars-cOv-2

... du SARS-CoV-2 est très similaire à celle des coronavirus de ...le SARS-CoV et le MERS-CoV et peut causer la mort dans les cas ...du SARS-CoV-2 peuvent être ... Voir le document complet

191

Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant

Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant

... source of the Marseille-4 variant. First, this variant carries a new set of several mutations that seems to have appeared suddenly based on the analysis of all the genomes available worldwide, ... Voir le document complet

10

High seroprevalence of SARS-CoV-2 antibodies among people living in precarious situations in Ile de France

High seroprevalence of SARS-CoV-2 antibodies among people living in precarious situations in Ile de France

... definitions of overcrowding exist, in Europe and North America it is defined as more than one single person or couple per habitable room ...bathroom and 23.7% [20.8-26.8] their own kitchen. A recent ... Voir le document complet

26

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

... paraformaldehyde for 24 h, transferred to 70% ethanol, paraffin embedded within 7–10 days and block sectioned at 5 ...baked for 30–60 min at 65 ° C and then deparaffinized in xylene and ... Voir le document complet

24

Transplacental transmission of SARS-CoV-2 infection

Transplacental transmission of SARS-CoV-2 infection

... maps and institutional ...distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative ... Voir le document complet

8

New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA

New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA

... (8) Morgan, B. S.; Sanaba, B. G.; Donlic, A.; Karloff, D. B.; Forte, J. E.; Zhang, Y.; Hargrove, A. E. R-BIND: An Interactive Database for Exploring and Developing RNA-Targeted Chemical Probes. ACS ... Voir le document complet

5

View of Pericardial effusion: an underrated complication of SARS-CoV-2

View of Pericardial effusion: an underrated complication of SARS-CoV-2

... De plus en plus de cas d’atteinte myocardique [2, 4] sont rapportés avec une prévalence d’environ 20 % [1] mais, à notre connaissance, seuls 3 cas d’épanchements péricardiques ont été rapportés dans la ... Voir le document complet

4

Xenotransplantation: in vitro analysis of synthetic α-galactosyl inhibitors of human anti-Galα1→3Gal IgM and IgG antibodies

Xenotransplantation: in vitro analysis of synthetic α-galactosyl inhibitors of human anti-Galα1→3Gal IgM and IgG antibodies

... Department of Medical Chemistry, Vrije Universiteit, NL-1081 BT Amsterdam, The Netherlands Received on April 19, 1999; revised on July 12, 1999; accepted on July 22, 1999 Pig-to-human xenotransplantation might be ... Voir le document complet

8

Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia

Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia

... context of COVID-19, serological testing is a valuable strategy for the diagnosis and the characterization of the course of the disease, for identifying convalescent plasma ... Voir le document complet

7

Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus

Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus

... du SARS- Cov-2, plus spécifiquement dans la région codant pour le domaine de liaison au récepteur cellulaire ...le SARS-Cov-2 tombe à 70 %, alors qu’il est supérieur à 96 % ... Voir le document complet

15

Data stream dataset of SARS-CoV-2 genome

Data stream dataset of SARS-CoV-2 genome

... representation of the COVID-2019 epi- demic virus ...science, and computing engineering disciplines can benefit from these data because by using this numeric representation, they can apply several stream ... Voir le document complet

11

Syndrome de Guillain-Barré et infection au SARS-CoV-2

Syndrome de Guillain-Barré et infection au SARS-CoV-2

... francoise.chapon@ unicaen.fr Commentaires Cet article est le premier rapportant plusieurs cas de GBS associés à la Covid-19. La relation entre les deux affections apparaît nette étant donné le délai bref d’installation ... Voir le document complet

2

Immunité adaptative contre le virus SARS-CoV-2

Immunité adaptative contre le virus SARS-CoV-2

... le SARS-CoV-2 et plus de 860 000 décès ont été recensés 1 ...de 2 à 8 % des personnes infectées selon les régions [1] ...(ou SARS), une insuffisance respiratoire, un choc, une ... Voir le document complet

6

Show all 10000 documents...